Korean J Urol.  1998 Feb;39(2):182-187.

Recovery from Abnormal Spermatogenesis after Exposure to Solvent 5200

Affiliations
  • 1Department of Urology, College of Medicine, University of Ulsan, Ulsan, Korea.

Abstract

PURPOSE: Solvent 5200(heptane 1.97%, 2-bromopropane 97.92% and 1,2-dibromopropane 0.02%) is a widely used detergent in electronic industries. The toxic effect of this chemical on spermatogenesis were investigated.
MATERIALS AND METHODS
Eight employees who showed abnormal semen analyses after exposure to Solvent 5200 for one year to eleven years underwent hormonal tests, semen analyses, testicular biopsies one month after cessation of exposure and then three consecutive semen analyses during 8 months follow-up period.
RESULTS
All patients(mean age: 33 years old) had decreased sperm count including azoospermia in one Patient. Five patients also had decreased sperm motility. One azoospermic and two oligospermic patients had elevated serum FSH level. Histology of testes in six patients showed abnormal histologic findings such as atrophy of seminiferous tubules, thickening of the basement membrane and hyperplasia of Leydig cells. Follow-up semen analysis during eight months period after cessation of exposure to Solvent 5200 revealed increased sperm count in all patients including four patients recovering to normal range.
Conclusion
Our studies suggest that Solvent 5200 could induce histolcgic change of testes as well as impairment of spermatogenesis and this process could be reversed by avoidance of exposure to this chemical substance.

Keyword

Spermatogenesis; Chemicals; Occupational; Testis

MeSH Terms

Atrophy
Azoospermia
Basement Membrane
Biopsy
Detergents
Follow-Up Studies
Humans
Hyperplasia
Leydig Cells
Male
Reference Values
Semen Analysis
Seminiferous Tubules
Sperm Count
Sperm Motility
Spermatogenesis*
Testis
Detergents
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr